| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Thermopylae Holdings Ltd. is 10% Owner at ABCL. From June 2021 to February 2026, the filings on record show 12 open-market purchases and 1 sale.
Historically, Thermopylae Holdings Ltd.'s trades have earned a middling insider score of 64/100 across 14 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -2.3%.
The ABCL filings lean toward selling, a net 2,277,653 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 1,408,468 | $6.41 | $9,021,800.93 | +2.6% | +98.8% | -14.5% | |
| Nov 11, 2021 | ABCL Abcellera Biologics Inc. | 10% Owner | Buy | 202,960 | $14.76 | $2,995,912.86 | +0.4% | -35.7% | -9.8% | |
| Jun 9, 2021 | ABCL Abcellera Biologics Inc. | 10% Owner | Sell | 5,598,420 | $24.03 | $134,530,032.60 | -9.1% | -20.5% | -64.8% |